标题:Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
作者:Wang, Q.; Su, L.; Liu, N.; Zhang, L.; Xu, W.; Fang, H.
作者机构:[Wang, Q.; Su, L.; Liu, N.; Zhang, L.; Xu, W.; Fang, H.] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China.; 更多
通讯作者:Fang, H
通讯作者地址:[Fang, H]Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, 44 W Culture Rd, Jinan 250012, Shandong, Peoples R China.
来源:CURRENT MEDICINAL CHEMISTRY
出版年:2011
卷:18
期:13
页码:2025-2043
DOI:10.2174/092986711795590110
关键词:Cyclin dependent kinases; cell cycle; mitosis; G2 phase; tumor; CDK1; inhibitors; cancer therapy agents
摘要:Cyclin dependent kinases (CDKs) are a family of proteins involved in the regulation of cell cycle progression and attractive targets in oncology. The regulation of CDKs activities is achieved by their association with cyclin partners and kinases, phosphatases and specific inhibitors. Different CDKs complexes exert their functions at different phases. CDK1 is a master modulator in the initiation and transition process through mitosis of the cell cycle. Previous studies have shown that loss of CDK1 activity or the aberrant expression of CDK1 involved in G2 phase arrest and many tumor types, thereby validating CDK1 as a therapeutic target. Therefore, a surge of interest has been devoted to searching for potent CDK1 inhibitors as effective chemotherapeutic agents. Herein we focus, in this review, mainly on the studies about the structure, functions and different structure classes of potent CDK1 inhibitors.
收录类别:SCOPUS;SCIE
WOS核心被引频次:25
Scopus被引频次:27
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-79957937959&doi=10.2174%2f092986711795590110&partnerID=40&md5=3dcc02739696c3e95663a14f7f3f642f
TOP